vs
Side-by-side financial comparison of Gossamer Bio, Inc. (GOSS) and SIFCO INDUSTRIES INC (SIF). Click either name above to swap in a different company.
SIFCO INDUSTRIES INC is the larger business by last-quarter revenue ($24.0M vs $13.8M, roughly 1.7× Gossamer Bio, Inc.). SIFCO INDUSTRIES INC runs the higher net margin — 7.5% vs -342.3%, a 349.8% gap on every dollar of revenue. On growth, Gossamer Bio, Inc. posted the faster year-over-year revenue change (47.1% vs 14.8%).
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics for patients with serious immunology, inflammation and oncology conditions. It advances a pipeline of proprietary product candidates across multiple clinical phases, primarily serving healthcare markets in North America and other global regions.
SIFCO Industries, Inc. (SIFCO), is a global metal component manufacturer based in Cleveland, Ohio.
GOSS vs SIF — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $24.0M |
| Net Profit | $-47.2M | $1.8M |
| Gross Margin | — | 21.6% |
| Operating Margin | -333.6% | 10.7% |
| Net Margin | -342.3% | 7.5% |
| Revenue YoY | 47.1% | 14.8% |
| Net Profit YoY | -43.0% | 177.3% |
| EPS (diluted) | $-0.21 | $0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $24.0M | ||
| Q3 25 | $13.3M | $22.8M | ||
| Q2 25 | — | $22.1M | ||
| Q1 25 | — | $19.0M | ||
| Q4 24 | — | $20.9M | ||
| Q3 24 | — | $21.7M | ||
| Q2 24 | $95.8M | $22.0M | ||
| Q1 24 | $0 | $20.5M |
| Q4 25 | $-47.2M | $1.8M | ||
| Q3 25 | $-48.2M | $-429.0K | ||
| Q2 25 | — | $3.4M | ||
| Q1 25 | — | $-1.4M | ||
| Q4 24 | — | $-2.3M | ||
| Q3 24 | — | $-443.0K | ||
| Q2 24 | $49.2M | $72.0K | ||
| Q1 24 | $-41.9M | $-1.6M |
| Q4 25 | — | 21.6% | ||
| Q3 25 | — | 9.6% | ||
| Q2 25 | — | 26.7% | ||
| Q1 25 | — | 8.3% | ||
| Q4 24 | — | 4.4% | ||
| Q3 24 | — | 10.7% | ||
| Q2 24 | — | 12.3% | ||
| Q1 24 | — | 7.3% |
| Q4 25 | -333.6% | 10.7% | ||
| Q3 25 | -369.4% | -1.7% | ||
| Q2 25 | — | 14.8% | ||
| Q1 25 | — | -4.1% | ||
| Q4 24 | — | -9.2% | ||
| Q3 24 | — | -1.5% | ||
| Q2 24 | 54.3% | 0.7% | ||
| Q1 24 | — | -6.5% |
| Q4 25 | -342.3% | 7.5% | ||
| Q3 25 | -362.7% | -1.9% | ||
| Q2 25 | — | 15.4% | ||
| Q1 25 | — | -7.3% | ||
| Q4 24 | — | -11.1% | ||
| Q3 24 | — | -2.0% | ||
| Q2 24 | 51.4% | 0.3% | ||
| Q1 24 | — | -7.8% |
| Q4 25 | $-0.21 | $0.29 | ||
| Q3 25 | $-0.21 | $-0.07 | ||
| Q2 25 | — | $0.56 | ||
| Q1 25 | — | $-0.23 | ||
| Q4 24 | — | $-0.38 | ||
| Q3 24 | — | $-0.07 | ||
| Q2 24 | $0.22 | $0.01 | ||
| Q1 24 | $-0.19 | $-0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $136.9M | $1.1M |
| Total DebtLower is stronger | — | $39.0K |
| Stockholders' EquityBook value | $-122.8M | $38.7M |
| Total Assets | $172.2M | $74.9M |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $136.9M | $1.1M | ||
| Q3 25 | $180.2M | $491.0K | ||
| Q2 25 | — | $2.0M | ||
| Q1 25 | — | $1.9M | ||
| Q4 24 | — | $3.1M | ||
| Q3 24 | — | $1.7M | ||
| Q2 24 | $354.5M | $3.4M | ||
| Q1 24 | $244.4M | $2.5M |
| Q4 25 | — | $39.0K | ||
| Q3 25 | — | $51.0K | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $3.6M | ||
| Q1 24 | — | $4.1M |
| Q4 25 | $-122.8M | $38.7M | ||
| Q3 25 | $-82.3M | $36.9M | ||
| Q2 25 | — | $35.8M | ||
| Q1 25 | — | $32.4M | ||
| Q4 24 | — | $33.7M | ||
| Q3 24 | — | $30.4M | ||
| Q2 24 | $81.5M | $29.8M | ||
| Q1 24 | $26.7M | $29.7M |
| Q4 25 | $172.2M | $74.9M | ||
| Q3 25 | $208.8M | $73.4M | ||
| Q2 25 | — | $77.3M | ||
| Q1 25 | — | $78.8M | ||
| Q4 24 | — | $81.0M | ||
| Q3 24 | — | $104.6M | ||
| Q2 24 | $373.4M | $106.3M | ||
| Q1 24 | $259.4M | $104.2M |
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | — | 0.14× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.3M | $8.1M |
| Free Cash FlowOCF − Capex | — | $8.0M |
| FCF MarginFCF / Revenue | — | 33.3% |
| Capex IntensityCapex / Revenue | 0.0% | 0.4% |
| Cash ConversionOCF / Net Profit | — | 4.51× |
| TTM Free Cash FlowTrailing 4 quarters | — | $11.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.3M | $8.1M | ||
| Q3 25 | $-36.2M | $726.0K | ||
| Q2 25 | — | $371.0K | ||
| Q1 25 | — | $2.8M | ||
| Q4 24 | — | $-3.8M | ||
| Q3 24 | — | $857.0K | ||
| Q2 24 | $116.3M | $382.0K | ||
| Q1 24 | $-52.3M | $-3.2M |
| Q4 25 | — | $8.0M | ||
| Q3 25 | — | $566.0K | ||
| Q2 25 | — | $310.0K | ||
| Q1 25 | — | $2.7M | ||
| Q4 24 | — | $-3.9M | ||
| Q3 24 | — | $580.0K | ||
| Q2 24 | — | $-175.0K | ||
| Q1 24 | — | $-3.9M |
| Q4 25 | — | 33.3% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 1.4% | ||
| Q1 25 | — | 14.1% | ||
| Q4 24 | — | -18.8% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | -0.8% | ||
| Q1 24 | — | -18.9% |
| Q4 25 | 0.0% | 0.4% | ||
| Q3 25 | 0.0% | 0.7% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 1.3% | ||
| Q2 24 | 0.0% | 2.5% | ||
| Q1 24 | — | 3.3% |
| Q4 25 | — | 4.51× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.36× | 5.31× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GOSS
Segment breakdown not available.
SIF
| Fixed Wing Aircraft Revenue | $10.5M | 44% |
| Commercial Revenue | $8.7M | 36% |
| Commercial Product And Other Revenue | $2.8M | 12% |
| Commercial Space | $1.1M | 5% |
| Other | $840.0K | 4% |
